Thrivent Financial for Lutherans decreased its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 98.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 74,075 shares of the company's stock after selling 5,789,855 shares during the quarter. Thrivent Financial for Lutherans' holdings in Option Care Health were worth $1,719,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the company. FMR LLC lifted its position in Option Care Health by 134.0% during the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company's stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Townsquare Capital LLC lifted its position in shares of Option Care Health by 6.2% during the 3rd quarter. Townsquare Capital LLC now owns 72,675 shares of the company's stock worth $2,275,000 after purchasing an additional 4,258 shares during the last quarter. CreativeOne Wealth LLC grew its holdings in Option Care Health by 21.9% in the 3rd quarter. CreativeOne Wealth LLC now owns 14,380 shares of the company's stock valued at $450,000 after buying an additional 2,585 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Option Care Health by 84.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 70,119 shares of the company's stock worth $2,195,000 after buying an additional 32,142 shares during the period. Finally, Martingale Asset Management L P acquired a new position in shares of Option Care Health during the third quarter worth approximately $287,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on OPCH shares. JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a "neutral" rating and a $26.00 price objective on the stock. Barrington Research lifted their target price on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their price target for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, JMP Securities reiterated a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.
Get Our Latest Analysis on Option Care Health
Option Care Health Trading Up 0.5 %
Option Care Health stock traded up $0.19 during trading hours on Tuesday, reaching $35.14. 387,752 shares of the company's stock traded hands, compared to its average volume of 1,707,989. The firm's 50 day moving average is $32.58 and its 200-day moving average is $28.40. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a market capitalization of $5.77 billion, a price-to-earnings ratio of 29.51, a PEG ratio of 2.30 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.
Insider Activity
In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is currently owned by company insiders.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
